# COO · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** COO  
**Sources:** 15  
**Published:** 2026-09-07  
**Canonical:** https://app.k3vl4r.com/research/deep-research-coo-catalysts-narrative-risks-3434

---

# Cooper Companies (NASDAQ: COO) — Research Brief

**Context.** The Cooper Companies, Inc. operates as a global medical device company through two business units: CooperVision (contact lenses) and CooperSurgical (fertility and women's health) [[13]](https://www.stocktitan.net/news/COO/), [[15]](https://investor.coopercos.com/). As of September 13, 2026, it carries an approximate market capitalization of ~$10.25B (point-in-time figure). The following is a synthesis of recent sources, not investment advice.

## Recent Catalysts (last ~1–3 months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-coo-catalysts-narrative-risks-3434 (free to sign up)._